- sales@expolake.com
- +1-469-567-9589
As the world’s premier biotechnology conference, BIO International Convention 2026 connects the complete life sciences ecosystem under one roof. From biotechnology startups and pharmaceutical companies to investors, academic institutions, and government agencies, the event creates a powerful environment for innovation, networking, and business growth.
The directory offers direct access to attendees and exhibitors representing biotechnology firms, pharmaceutical manufacturers, research organizations, healthcare innovators, investors, and life science service providers.
Verified Attendees
Exhibiting Companies
Accuracy
Delivery Time
Verification Layers
BIO International Convention 2026 is the world’s largest and most influential event for biotechnology, life sciences, pharmaceuticals, and healthcare innovation, bringing together more than 20,000 industry leaders and 900+ exhibitors from across the global life sciences ecosystem. Hosted at the San Diego Convention Center, the event serves as a global meeting point for biotechnology companies, pharmaceutical organizations, investors, researchers, academic institutions, government agencies, and healthcare innovators.
The exhibition showcases the complete biotechnology value chain, including drug discovery, cell and gene therapy, genome editing, biomanufacturing, clinical research, diagnostics, healthcare technologies, and pharmaceutical services. Visitors gain direct access to groundbreaking innovations, investment opportunities, scientific expertise, and strategic partnerships that are shaping the future of healthcare.
Beyond the exhibition floor, BIO International Convention 2026 provides outstanding opportunities for networking, collaboration, and business development through BIO Partnering™, educational sessions, company presentations, startup showcases, international pavilions, and expert-led discussions focused on advancing biotechnology innovation worldwide.
BIO International Convention 2026 serves as a meeting point for organizations driving innovation across biotechnology, pharmaceuticals, healthcare, and life sciences.
Companies developing novel therapies, diagnostics, and scientific solutions.
Industry leaders focused on drug research, development, and manufacturing.
Organizations supporting biotechnology growth and innovation.
Businesses introducing innovative healthcare platforms and medical technologies.
Scientific organizations advancing healthcare and biotechnology discoveries.
Organizations supporting clinical research, regulatory compliance, and commercialization.
Organizations developing innovative therapeutics, diagnostics, and biotechnology solutions.
Leaders responsible for drug discovery, development, manufacturing, and commercialization.
Organizations seeking promising biotechnology innovations and investment opportunities.
Experts driving advancements in biotechnology, healthcare, and life sciences.
Professionals developing next-generation healthcare technologies and solutions.
Decision-makers shaping the future of biotechnology, pharmaceuticals, and healthcare innovation.
Access detailed attendee and exhibitor information from BIO International Convention 2026 to support lead generation, partnership development, investor outreach, licensing opportunities, and business growth across the biotechnology and life sciences industries.
Connect with professionals evaluating new technologies, therapies, research platforms, and healthcare innovations.
Access executives responsible for biotechnology innovation, pharmaceutical development, scientific research, and investment decisions.
Promote your solutions to a highly targeted audience of biotechnology and life sciences professionals.
Identify qualified prospects actively seeking biotechnology products, services, and strategic partnerships.
Build relationships with organizations across global biotechnology and pharmaceutical markets.
Turn valuable industry connections into partnerships, investments, and commercial growth.
Get verified attendee and exhibitor contact lists from past and upcoming event editions worldwide. ExpoLake delivers accurate, segmented B2B contact data covering key decision-makers and exhibiting companies, so your outreach always reaches the right person at the right time.
Connect with professionals evaluating new therapies, research technologies, healthcare solutions, and pharmaceutical services.
Access executives, scientists, researchers, and investors shaping the future of healthcare and biotechnology.
Identify scientists, academic institutions, and research organizations advancing biotechnology innovation.
Reach venture capital firms, private equity groups, and strategic investors searching for breakthrough opportunities.
Launch highly targeted marketing campaigns to qualified biotechnology audiences.
Generate valuable opportunities that support long-term expansion and market development.
Every contact in the ExpoLake database goes through a structured, multi-step sourcing and verification process before it reaches your team. Here is how we build data you can trust.
Contacts are gathered from trade shows, global directories, e-books, newsletters, and digital publications spanning dozens of industries and regions.
Machine learning fills missing fields, appends firmographic data, and segments contacts by industry, role, company size, and intent signals — automatically.
Every record is cross-checked against our master database and validated via social platforms, public registries, and news sources to confirm authenticity.
Anomalies, duplicates, and stale entries are flagged using statistical models and eliminated. A final manual audit ensures the highest standard of data quality.
A/B-tested opt-in email sequences are deployed to capture and confirm explicit consent, fully aligned with GDPR, CAN-SPAM, and CASL compliance frameworks.
A final tele-verification call confirms all data fields. Only fully validated, consented records are released to the client — clean, compliant, and ready to use.
The directory provides access to biotechnology executives, pharmaceutical leaders, researchers, scientists, investors, healthcare innovators, academic institutions, CROs, CDMOs, and life sciences decision-makers attending the world’s largest biotechnology conference.
Yes. Contacts can be filtered by battery segment, geography, company size, revenue range, purchasing authority, job title, industry category, and seniority level.
Available fields may include names, job titles, business emails, phone numbers, company information, websites, locations, research interests, purchasing authority, and company classifications.
Yes. You can choose attendee contacts, exhibitor contacts, biotechnology professionals, pharmaceutical executives, researchers, investors, healthcare innovators, or a combined database based on your business objectives.
Absolutely. It helps biotechnology companies, pharmaceutical manufacturers, healthcare organizations, CROs, CDMOs, research institutions, and life sciences service providers connect with qualified buyers and decision-makers.
Yes. Audience segments can be tailored for biotechnology, pharmaceuticals, cell and gene therapy, genome editing, biomanufacturing, diagnostics, healthcare technology, clinical research, and life sciences services.
The directory supports lead generation, licensing opportunities, investor outreach, partnership development, customer acquisition, market expansion, scientific collaboration, business networking, and long-term growth across the global biotechnology and life sciences ecosystem.
